Press releases
Fitabeo Therapeutics Secures Patent for Innovative Drug Delivery Technology
Fitabeo Therapeutics, a clinical-stage specialty pharmaceutical company and University of Strathclyde spin-out has announced the grant of a new patent for its groundbreaking drug delivery technology in Japan
- August 20, 2024
Fitabeo Therapeutics appoints Dr Parameswara Rao Vuddanda to lead Technology and Product Development
Dr Parameswara Rao Vuddanda has been appointed as Development Director, to accelerate Technology and Product Development and drive Fitabeo Therapeutics’
- July 12, 2023
Fitabeo Therapeutics and ILC Therapeutics join forces to develop novel hybrid interferon-based medicines
Partnership is aimed at accelerating the development of new treatments based on novel hybrid interferons to treat serious, unmet medical
- May 4, 2023
Fitabeo Therapeutics and Pharmanovia enter strategic partnership to improve the patient experience of two of its established medicines
Partnership will explore treatment adherence and overall health outcomes for patients for established medicines in the Pharmanovia range, using innovative
- February 10, 2023
Fitabeo Therapeutics launches with the goal to provide solutions for pressing healthcare challenges. Appoints industry veteran Jodi Devlin as Chair
Fitabeo Therapeutics has ‘spun-out’ from the University of Strathclyde with ambitious plans to address some of society’s most pressing healthcare
- December 12, 2022
